7-(4-(2-(5-chlorothiophen-2-yl)-2-(methoxyimino)ethyl)piperazin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

ID: ALA1290114

Chembl Id: CHEMBL1290114

PubChem CID: 52946070

Max Phase: Preclinical

Molecular Formula: C24H24ClFN4O4S

Molecular Weight: 519.00

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CO/N=C(/CN1CCN(c2cc3c(cc2F)c(=O)c(C(=O)O)cn3C2CC2)CC1)c1ccc(Cl)s1

Standard InChI:  InChI=1S/C24H24ClFN4O4S/c1-34-27-18(21-4-5-22(25)35-21)13-28-6-8-29(9-7-28)20-11-19-15(10-17(20)26)23(31)16(24(32)33)12-30(19)14-2-3-14/h4-5,10-12,14H,2-3,6-9,13H2,1H3,(H,32,33)/b27-18-

Standard InChI Key:  BYJWUKCDKCWCJS-IMRQLAEWSA-N

Associated Targets(Human)

MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL3 (228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EJ (302 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SW480 (6023 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 519.00Molecular Weight (Monoisotopic): 518.1191AlogP: 4.06#Rotatable Bonds: 7
Polar Surface Area: 87.37Molecular Species: ACIDHBA: 8HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 5.59CX Basic pKa: 4.32CX LogP: 4.05CX LogD: 2.41
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.37Np Likeness Score: -1.26

References

1. Korolyov A, Dorbes S, Azéma J, Guidetti B, Danel M, Lamoral-Theys D, Gras T, Dubois J, Kiss R, Martino R, Malet-Martino M..  (2010)  Novel lipophilic 7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid derivatives as potential antitumor agents: improved synthesis and in vitro evaluation.,  18  (24): [PMID:21067931] [10.1016/j.bmc.2010.10.039]
2. Gao F, Zhang X, Wang T, Xiao J..  (2019)  Quinolone hybrids and their anti-cancer activities: An overview.,  165  [PMID:30660827] [10.1016/j.ejmech.2019.01.017]
3. Ahadi H, Emami S..  (2020)  Modification of 7-piperazinylquinolone antibacterials to promising anticancer lead compounds: Synthesis and in vitro studies.,  187  [PMID:31881454] [10.1016/j.ejmech.2019.111970]

Source